← Evidence map

ReviewCancers2022

Mesothelin: An Immunotherapeutic Target beyond Solid Tumors.

Joshua R Faust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

66 papers cite itlatest 60 shown

2022
…
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35326701